hyaluronic acid based products  anika therapeutics overview overview orthobiologics orthovisc orthovisc mini monovisc cingal hyalofast hyalonect hyaloglide dermal hyalomatrix hyalofill hyalogran hyalosafe elevess surgical hyalobarrier incerts ent – epidisc – epidisc tm – epifilm – merogel – merogel injectable other ha solutions anikavisc hyaloss matrix hyvisc our products anika therapeutics manufactures and distributes a diverse portfolio of hyaluronic acid ha based products covering a broad range of therapeutic applications orthobiologics safe and natural solutions help restore active function dermal naturally powerful solutions to enhance natural beauty and manage wounds surgical safe and natural protection against adhesions other ha solutions ophthalmic dental and veterinary anika therapeutics  global medical technologies  pain management tissue regeneration wound healing about us orthobiologics dermal surgical return to life naturally learn more feel stronger go further get moving enhance natural beauty manage wounds explore dermal protection against adhesions safety matters back next clinical trials a clinical trial involves research using human volunteers and is intended to collect data that will add to medical knowledge below are our products that currently have an ongoing clinical trial click the product to learn more hyalofast technology inspired by nature perfected by science anika is a leading manufacturer of products designed to help protect heal and regenerate tissue our proprietary technology is based on hyaluronic acid ha a naturally occurring biocompatible molecule found throughout the body and a vital component of healthy joint and tissue function learn more back next products orthobiologics safe and natural solutions help restore active function anika’s orthobiologics products are designed to help patients return to their active lives more quickly and naturally our comprehensive portfolio of viscosupplementation products addresses the joint pain associated with osteoarthritis learn more products dermal naturally powerful solutions to enhance natural beauty and manage wounds anika offers a range of therapeutic solutions designed for wound management and the enhancement of natural beauty our proprietary technology utilizes naturallysourced hyaluronic acid ha a natural component of the body vital for maintaining the elasticity and function of healthy tissue learn more products surgical safe and natural protection against adhesions hyaluronic acid ha is a naturally occurring polymer found throughout the body ha is vital for maintaining the function of healthy tissue and can be used for a variety of applications anika’s innovative allnatural habased barriers work to prevent or reduce postsurgical adhesions learn more products other ha solutions naturally inspired therapeutics anika’s other product solutions address a broad range of therapeutic areas including ophthalmic dental and veterinary learn more spotlight cingal is the first and only approved hyaluronic acid ha plus steroid combination product proven to provide fast acting and long lasting pain relief cingal is not approved for use in the usa learn more contact us  wiggins avenue bedford ma  ph  careers at anika learn more about us  innovation  consistent performance in therapeutic products  anika therapeutics about us overview executive management team history distributor partners contact us return to life naturally who we are we are anika therapeutics a global medical technology company at the forefront of pain management tissue regeneration and wound healing we are committed to delivering innovative medical solutions that help patients feel better faster look and feel younger and remain active with over  million procedures performed in the past twentyfive years utilizing our proprietary technology anika is helping individuals all over the world return to life naturally our guiding principles we are innovators and creators we value strong discipline and exceptional focus from our personnel and we employ lean principles and agile processes in managing our business this foundation of guiding values combined with our entrepreneurial spirit gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products watch the anika therapeutics corporate video what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care and skin rejuvenation our proprietary technology is based on hyaluronic acid ha a naturally occurring polymer found throughout the body vital for proper joint health and tissue function why we do it at anika we believe that an individual’s feelings about their age are driven by perceptions about the state of their body therefore our products endeavor to help you feel younger and remain active by delivering safe effective and minimally invasive treatments to manage pain restore joint health and tissue function and support wound healing our partners we value lasting global commercial relationships with companies whose strengths and values complement our own since our founding we have worked tirelessly to forge longterm collaborations with industry leaders including depuy synthes mitek sports medicine inc medtronic inc and boehringer ingelheim vetmedica inc to deliver new therapeutic products and to advance healthcare opportunities for our customers our performance during our more than two decades of operation anika has earned its reputation as a very reliable performer in the industry known for its consistent ability to deliver solid growth and a strong pipeline of innovative product extensions and new products to the market while we take pride in our past performance we are even more excited about our future and the opportunities in front of us anik key statistics  anika therapeutics inc financial ratios  marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close anika therapeutics inc nasdaq anik go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus anika therapeutics inc after hours  quotes are delayed by  min jul    pm anik quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description anika therapeutics inc is global medical technology company which develops manufactures and commercializes therapeutic products for pain management tissue regeneration and wound healing the companys products are based on hyaluronic acid a natural chemical occurring biocompatible polymer fou anika therapeutics inc is global medical technology company which develops manufactures and commercializes therapeutic products for pain management tissue regeneration and wound healing the companys products are based on hyaluronic acid a natural chemical occurring biocompatible polymer found throughout the body it offers therapeutic products which include orthobiologics dermal ophthalmic surgical and veterinary anika therapeutics was founded in  and is headquartered in bedford ma valuation pe current  pe ratio with extraordinary items  pe ratio without extraordinary items  price to sales ratio  price to book ratio  price to cash flow ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title dr charles h sherwood   president chief executive officer  director ms dana m alexander   chief operating officer ms sylvia cheung   chief financial officer secretary  treasurer dr edward s ahn   chief technology  strategy officer mr richard hague   chief commercial officer insider actions – purchase – sale  – number of transactions  date name shares transaction value  charles h sherwood president ceo director director    disposition at  per share   charles h sherwood president ceo director director    disposition at  per share   jeffery s thompson director    disposition at  per share   jeffery s thompson director    disposition at  per share   edward s ahn chief tech  strategy officer    disposition at  per share   sylvia cheung chief financial officer    disposition at  per share   sylvia cheung chief financial officer    disposition at  per share   sylvia cheung chief financial officer    disposition at  per share   raymond j land director    disposition at  per share   sylvia cheung chief financial officer    derivativenonderivative trans at  per share   sylvia cheung chief financial officer    derivativenonderivative trans at  per share   sylvia cheung chief financial officer    derivativenonderivative trans at  per share   joseph l bower director    award at  per share   steven e wheeler director    award at  per share   raymond j land director    award at  per share   glenn r larsen director    award at  per share   jeffery s thompson director    award at  per share   joseph l bower director    disposition at  per share   joseph l bower director    disposition at  per share   joseph l bower director    derivativenonderivative trans at  per share   joseph l bower director    derivativenonderivative trans at  per share   steven e wheeler director    derivativenonderivative trans at  per share  newslatestcompanyusanik marketwatch news on anik how ‘panic buying’ could send stock market rally into overdrive  am march    shawn langlois wall street expects these healthcare stocks to rise up to   pm may    philip van doorn the most profitable companies get the best stock returns  am oct    philip van doorn these eight healthcare stocks could rise up to   pm aug    philip van doorn closing out an unseasonally strong may  am may    michael ashbaugh two names for a twoway stock market  pm may    the trading deck nasdaq treads water while a few names show their stuff  pm may    the trading deck dow edges to lesscharted technical territory  am may    michael ashbaugh dow edges to lesscharted territory  am may    michael ashbaugh sp  extends the break to ‘clear skies’ territory  am march    michael ashbaugh stock futures edge higher ahead of home sales  am feb    william l watts first solar shares burned as earnings disappoint  pm feb    wallace witkowski amgen boosts biotech sector to close up  pm march    wallace witkowski human genome rallies against biotech downturn  pm march    wallace witkowski illumina dives anika rallies on earnings reports  am oct    val brickates kennedy genzyme merck lead as drug stocks move higher  pm aug    val brickates kennedy thursdays biggest gaining and declining stocks  pm aug    marketwatch drug stocks gain anika zooms on drug approval  pm aug    val brickates kennedy wednesdays biggest stock gainers and decliners  pm july    gabriel madway stocks in focus for wednesday  pm july    marketwatch loading more headlines newsnonmarketwatchcompanyusanik other news on anik notable earnings after wednesday’s close  pm july    seeking alpha the zacks analyst blog highlights valeant pharmaceuticals international flexion therapeutics ignyta and anika therapeutics  am july    zackscom  sellranked drug stocks to avoid ahead of q earnings  am july    zackscom anika therapeutics anik presents at singular summer solstice conference  slideshow  am july    seeking alpha new strong sell stocks for july th  am july    zackscom  naked puts to bank plus in july cash  am july    investorplacecom  cheap stocks with growing book value  am june    gurufocuscom anika therapeutics robust growth  huge margins at a bargain price  am june    seeking alpha anika therapeutics launches supplemental latestage study of cingal for osteoarthritis of the knee  pm may    seeking alpha anika therapeutics anik ceo charles sherwood on q  results  earnings call transcript  pm may    seeking alpha anika therapeutics inc  q  results  earnings call slides  am may    seeking alpha  stocks young warren buffett would buy in   pm may    gurufocuscom q anika therapeutics inc  pm may    edgar online  edg  q k notable earnings after wednesday’s close  pm may    seeking alpha  companies that offer strong value potential for ndquarter   pm march    gurufocuscom anika therapeutics anik presents at canaccord genuity musculoskeletal conference  pm march    seeking alpha implied volatility surging for anika therapeutics anik stock options  am march    zackscom k anika therapeutics inc  pm feb    edgar online  edg  q k anika therapeutics anik ceo charles sherwood on q  results  earnings call transcript  pm feb    seeking alpha anika therapeutics inc  q  results  earnings call slides  am feb    seeking alpha loading more headlines at a glance anika therapeutics inc  wiggins avenue bedford massachusetts  phone   industry medical equipmentsupplies sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for anik newspressreleasecompanyusanik press releases on anik anika announces regulatory approval for monovisc® in india for the treatment of pain associated with osteoarthritis of all synovial joints  pm july    businesswire  bzx anika announces  million milestone payment from us commercial sales of monovisc  pm july    businesswire  bzx anika to issue secondquarter  financial results and business highlights on wednesday july   pm july    businesswire  bzx anika to present at the singular research summer solstice conference on july    pm july    businesswire  bzx csa medical appoints jean bjerke vice president of marketing  pm june    pr newswire  prf anika announces data presentation and symposium on cingal at  efort annual congress  pm may    businesswire  bzx anika announces first patient enrolled in supplemental phase iii trial of cingal for the treatment of knee pain associated with osteoarthritis  pm may    businesswire  bzx anika celebrates th anniversary and inaugurates newly expanded and consolidated global manufacturing facility in bedford massachusetts  am may    businesswire  bzx anika announces publication of phase iii data demonstrating the efficacy and safety of cingal® for the treatment of knee pain associated with osteoarthritis  am may    businesswire  bzx investor network anika therapeutics inc to host earnings call  am may    accesswire anika reports first quarter  financial results  pm may    globenewswire anika to issue firstquarter  financial results and business highlights on wednesday may   pm april    businesswire  bzx dermal filler market clinics and hospital pharmacies most popular distribution segment north america and europe industry analysis and opportunity assessment   pm april    pr newswire  prf anika to present at the  canaccord genuity musculoskeletal conference on march    pm feb    businesswire  bzx anika therapeutics inc nasdaq anik to ring the nasdaq stock market opening bell  am feb    globenewswire anika reports fourth quarter and full year  financial results  pm feb    businesswire  bzx anika to issue fourthquarter  financial results and business highlights on wednesday february   pm feb    businesswire  bzx dermal filler market clinics and hospital pharmacies most popular distribution segment north america and europe industry analysis and opportunity assessment   pm jan    pr newswire  prf anika wins ce mark approval for orthovisc®t to relieve pain and restore function of tendons damaged by chronic injury  pm dec    businesswire  bzx regenerative medicine market global industry analysis and opportunity assessment   pm dec    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest agkn earnings rise offers upbeat  outlook afrench consumer confidence drops sharply atullow oil swings to loss on impairment aitv rises  after dividend hike agermanys dax opens  point lower at  afrances cac  opens  higher at  auks ftse  opens  higher at  astoxx europe  opens  higher at  aantofagasta gold copper production rises athree ways draghi could burn the euro bulls afresnillo gold silver production rises aitv profit falls  but dividend is raised ahow china not trump trade is now lifting copper aaustralian inflation more muted than seen akpn on track to achieve targets as profit rises apeugeot net income rises  adaimler net profit boosted by record sales a reasons so many americans are getting the hell out of the northeast awynn macau net profit rises  on year ahere’s why oil just scored its biggest oneday rally of  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  investor relations  anika therapeutics investor relations email print share facebook google linkedin twitter email rss shareholder tools shareholder briefcase information request email alerts ir contacts virtual investor kit q  fact sheet rss feeds nasdaq anik     volume   pm et on jul   delayed at least  minutes corporate overview corporate governance executive management team board of directors committee composition chart stock information historic stock lookup investment calculator ownership profile analyst coverage sec filings annual reports and proxies quarterly results news releases events  presentations investor faqs investor relations headquartered in bedford massachusetts anika therapeutics inc develops manufactures and commercializes therapeutic products for tissue protection healing and repair our proprietary technology is based on hyaluronic acid ha a naturally occurring biocompatible polymer found throughout the body that is essential to joint health and tissue function anika’s products range from orthopedicjoint health solutions led by orthovisc® and monovisc® our multi and singleinjection treatments for osteoarthritis of the knee to surgical aids in the ophthalmic and antiadhesion fields the company also offers aesthetic dermal fillers for the correction of facial wrinkles anika’s italian subsidiary anika therapeutics srl provides a complementary product and technology portfolio comprised of habased products in the orthopedicsjoint health advanced wound care and ear nose and throat fields anika’s technology portfolio including anika therapeutics srl’s subsidiary’s regenerative tissue technology advances the company’s vision to offer therapeutic products that go beyond pain management to protect and restore damaged tissue the company’s approach has enabled anika to deliver longterm shareholder value by providing profitability and positive cashflow two rare characteristics for an entrepreneurial smallcap company that anika intends to retain as it grows in the industry news releases jul   anika announces regulatory approval for monovisc® in india for the treatment of pain associated with osteoarthritis of all synovial joints jul   anika announces  million milestone payment from us commercial sales of monovisc jul   anika to issue secondquarter  financial results and business highlights on wednesday july  view all news releases events  presentations jul   at  am et q  anika therapeutics earnings conference call listen to webcast view all events  presentations news releases view recent and archived news releases on acquisitions earnings events and general company news events and presentations listen to quarterly earnings calls and investor conference presentations sec filings download readerfriendly documents and access all sec filings corporate governance view committee charters governance documents and board committee assignments quarterly results download quarterly earnings releases and other related documents stock information access stock quotes and charts anika therapeutics inc nasdaqanik anika therapeutics inc anik product news news  stocknewscom     follow us stocktwits twitter anika therapeutics inc anik product news news anik – announces that regulatory authorities in india granted approval to monovisc for the treatment of pain associated with osteoarthritis of all human synovial joints jul    pm  by stocknewscom staff product news key facts surrounding this news item anik had a powr rating of b buy coming into today anik was  above its day moving average coming into today anik was  below its day moving average coming into today anik was  above its day moving average coming into today anik was  above its day moving average coming into today anik was  above its day moving average coming into today anik had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about anika therapeutics inc anik anika therapeutics develops manufactures and commercializes therapeutic products for tissue protection healing and repair the company was founded in  and is based in bedford massachusetts view our full anik ticker page with ratings news and more anik at a glance anik current powr rating™ overall powr rating™ anik current price   more anik ratings data and news anik price reaction the day of this event jul  anik closing price anik volume from avgleading up to this eventanik mo returnnaafter this eventanik day return anik price chart more anika therapeutics inc anik news view all eventdate symbol news detail start price end price change powr rating loading please wait view all anik news page generated in  seconds anika therapeutics inc anik  product pipeline analysis  update infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports anika therapeutics inc anik  product pipeline analysis anika therapeutics inc anik  product pipeline analysis  update wgr  april  global  pages globaldata description table of content sample report enquiry before buy related reports summary anika therapeutics inc anika is a medical technology company which develops manufactures and markets therapeutic products for tissue protection repair and regeneration it offers solutions for orthobiologics dermal ophthalmic surgical and veterinary applications its major products include viscosupplementation and regenerative orthopedics products advanced wound care devices antiadhesion gels viscoelastic ophthalmic products dental bone grafting adjuncts and joint dysfunction management fluids for horses its products are made from hyaluronic acid ha based on two technologies hyaff which is a solid form of ha and acp gel an autocrosslinked polymer of ha anika has research and manufacturing facilities in bedford massachusetts the company offers its products through distributors in the americas europe the middle east and asia anika is headquartered in massachusetts the us this report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage scope  the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments  the report analyzes all pipeline products in development for the company anika therapeutics inc  the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status  the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date  the report provides detailed description of products in development technical specification and functions  the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end date reasons to buy  develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape  design and develop your product development marketing and sales strategies by understanding the competitor portfolio  to formulate effective research  development strategies  develop marketentry and market expansion strategies  exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return  plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etc  identify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contents table of contents  list of tables  list of figures  anika therapeutics inc company overview  anika therapeutics inc company snapshot  anika therapeutics inc pipeline products and ongoing clinical trials overview  anika therapeutics inc – pipeline analysis overview  business description  anika therapeutics inc  key facts  anika therapeutics inc  major products and services  anika therapeutics inc pipeline products by development stage  anika therapeutics inc ongoing clinical trials by trial status  anika therapeutics inc pipeline products overview  cingal  cingal product overview  cronofill  cronofill product overview  hemostatic patch  hemostatic patch product overview  hyaff barrier film  hyaff barrier film product overview  hyaff gel  hyaff gel product overview  hyaff mesh  hyaff mesh product overview  hyaffacp spray  adhesion  hyaffacp spray  adhesion product overview  hyalobone  hyalobone product overview  hyalofast  hyalofast product overview  hyalofast clinical trial  hyaloglide  hyaloglide product overview  hyalograft c autograft  hyalograft c autograft product overview  hyalonect  hyalonect product overview  monovisc  monovisc product overview  monovisc  hip  monovisc  hip product overview  monovisc  hip clinical trial  next generation elevess dermal filler  next generation elevess dermal filler product overview  orthovisct  orthovisct product overview  anika therapeutics inc  key competitors  anika therapeutics inc  key employees  anika therapeutics inc  key employee biographies  anika therapeutics inc  locations and subsidiaries  head office  other locations  subsidiaries  recent developments  anika therapeutics inc recent developments  feb   anika therapeutics reports  revenue growth in third quarter   feb   anika reports fourth quarter and full year  financial results  dec   anika wins ce mark approval for orthovisct to relieve pain and restore function of tendons damaged by chronic injury  oct   anika reports third quarter  financial results  sep   anika announces data presentations on hyalofast hyaluronic acidbased scaffold at  world congress of the international cartilage repair society  jul   anika reports second quarter  financial results  jun   anika announces european commercial launch of cingal for the treatment of pain associated with osteoarthritis  may   pendopharm announces canadian launch of cingal in partnership with anika therapeutics  apr   anika reports first quarter  financial results  apr   anika appoints new chief medical officer and chief operations officer  appendix  methodology  about globaldata  contact us  disclaimer  list of tables anika therapeutics inc pipeline products and ongoing clinical trials overview  anika therapeutics inc pipeline products by equipment type  anika therapeutics inc pipeline products by indication  anika therapeutics inc ongoing clinical trials by trial status  anika therapeutics inc key facts  anika therapeutics inc major products and services  anika therapeutics inc number of pipeline products by development stage  anika therapeutics inc pipeline products summary by development stage  anika therapeutics inc ongoing clinical trials by trial status  anika therapeutics inc ongoing clinical trials summary  cingal  product status  cingal  product description  cronofill  product status  cronofill  product description  hemostatic patch  product status  hemostatic patch  product description  hyaff barrier film  product status  hyaff barrier film  product description  hyaff gel  product status  hyaff gel  product description  hyaff mesh  product status  hyaff mesh  product description  hyaffacp spray  adhesion  product status  hyaffacp spray  adhesion  product description  hyalobone  product status  hyalobone  product description  hyalofast  product status  hyalofast  product description  hyalofast  a prospective randomized active treatmentcontrolled evaluatorblinded multicenter study to establish the superiority of hyalofast with bmac in the treatment of articular knee cartilage defect lesions in comparison to control  hyaloglide  product status  hyaloglide  product description  hyalograft c autograft  product status  hyalograft c autograft  product description  hyalonect  product status  hyalonect  product description  monovisc  product status  monovisc  product description  monovisc  hip  product status  monovisc  hip  product description  monovisc  hip  investigational device exemption ide phase iii study of monovisc to treat pain caused by osteoarthritis of the hip  next generation elevess dermal filler  product status  next generation elevess dermal filler  product description  orthovisct  product status  orthovisct  product description  anika therapeutics inc key employees  anika therapeutics inc key employee biographies  anika therapeutics inc subsidiaries  glossary  list of figures anika therapeutics inc pipeline products by equipment type  anika therapeutics inc pipeline products by development stage  anika therapeutics inc ongoing clinical trials by trial status  request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm global medical ultrasonic baths market research report  in this report the global medical ultrasonic baths market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  global medical vacuum systems market research report  in this report the global medical vacuum systems market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  global nibp multiparameter monitors market research report  in this report the global nibp multiparameter monitors market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  global pulp vitality testers market research report  in this report the global pulp vitality testers market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  global root canal irrigators market research report  in this report the global root canal irrigators market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports global medical ultrasonic baths market research report  published  july  global medical vacuum systems market research report  published  july  global nibp multiparameter monitors market research report  published  july  global pulp vitality testers market research report  published  july  global root canal irrigators market research report  published  july  × tell a friend about this report your name your email friends name friends email your enquiry send microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft anika therapeutics anik  stock predictions  price targets facebook autocomplete demo post a rating  month price target   home trending sign up log in anika therapeutics inc anik median target price  positive ratings  latest  singular research  buy     view all analyst ratings for anik » facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising anika therapeutics  global medical technologies  pain management tissue regeneration wound healing about us orthobiologics dermal surgical return to life naturally learn more feel stronger go further get moving enhance natural beauty manage wounds explore dermal protection against adhesions safety matters back next clinical trials a clinical trial involves research using human volunteers and is intended to collect data that will add to medical knowledge below are our products that currently have an ongoing clinical trial click the product to learn more hyalofast technology inspired by nature perfected by science anika is a leading manufacturer of products designed to help protect heal and regenerate tissue our proprietary technology is based on hyaluronic acid ha a naturally occurring biocompatible molecule found throughout the body and a vital component of healthy joint and tissue function learn more back next products orthobiologics safe and natural solutions help restore active function anika’s orthobiologics products are designed to help patients return to their active lives more quickly and naturally our comprehensive portfolio of viscosupplementation products addresses the joint pain associated with osteoarthritis learn more products dermal naturally powerful solutions to enhance natural beauty and manage wounds anika offers a range of therapeutic solutions designed for wound management and the enhancement of natural beauty our proprietary technology utilizes naturallysourced hyaluronic acid ha a natural component of the body vital for maintaining the elasticity and function of healthy tissue learn more products surgical safe and natural protection against adhesions hyaluronic acid ha is a naturally occurring polymer found throughout the body ha is vital for maintaining the function of healthy tissue and can be used for a variety of applications anika’s innovative allnatural habased barriers work to prevent or reduce postsurgical adhesions learn more products other ha solutions naturally inspired therapeutics anika’s other product solutions address a broad range of therapeutic areas including ophthalmic dental and veterinary learn more spotlight cingal is the first and only approved hyaluronic acid ha plus steroid combination product proven to provide fast acting and long lasting pain relief cingal is not approved for use in the usa learn more contact us  wiggins avenue bedford ma  ph  careers at anika learn more yelp yelp sorry you’re not allowed to access this page contact yelp if you keep experiencing issues bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one